Rasagiline orally disintegrating compositions
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsShulamit Patashnik, Daniella Licht, Adrian Gilbert
Life of this patent
Estimating the term…
Loading patent…
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsShulamit Patashnik, Daniella Licht, Adrian Gilbert
Estimating the term…
This invention provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at least two sugar alcohols. This invention also provides a solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, a mixture of a disintegrant, a flow agent and particles having a non-filamentous microstructure of at least two sugar alcohols, a supplemental sugar alcohol, a supplemental flow agent, and a supplemental disintegrant. This invention further provides a method of treating a subject afflicted with Parkinson's disease comprising administering to the subject a therapeutically effective amount of the solid pharmaceutical composition, thereby treating the subject. Finally, this invention provides a process of making such solid pharmaceutical compositions.
A solid pharmaceutical composition comprising rasagiline or a pharmaceutically acceptable salt of rasagiline, and particles having a non-filamentous microstructure of at least two sugar alcohols.
3-4. (canceled)
(canceled)
8-11. (canceled)
13-15. (canceled)
(canceled)
(canceled)
21-22. (canceled)
28-29. (canceled)
A solid pharmaceutical composition comprising
32-65. (canceled)
68-69. (canceled)
A solid pharmaceutical composition comprising
71-87. (canceled)
Dependencies are inferred from the claim text.